Jiangxi Shtec Bioscience Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is TAZOBACTAM, with a corresponding US DMF Number 37889.
Remarkably, this DMF maintains an Active status since its submission on May 31, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 22, 2025, and payment made on March 24, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II